This is the limited version of the Tercica company profile: Join LinkedIn or Sign In to see more information.
Tercica was founded as a biotech company with a unique focus: to develop and commercialize new products to patients with endocrine diseases. Now part of the Ipsen group, we market Increlex, Somatuline Depot, and Apokyn. Our company is committed to fully embracing these underserved patient populations. That's why we offer distinct, novel products to help improve the lives of patients with these disorders.
Your Connections to Tercica
Popular Profiles at Tercica
Last edited by Senior Manager, Clinical Outsourcing at Pharmacyclics, Inc.
2000 Sierra Point Parkway
Suite 400
Brisbane, CA
94005
United States
Phone: 650-624-4900
Fax: 650-624-4940
| Top Schools |
| Univ. of California, Davis | 6% |
| Univ. of Michigan | 4% |
| Univ. of California, Berkeley | 3% |
| Univ. of Southern California | 3% |
|
Estimated based on LinkedIn Data
Career path for Tercica employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Tercica. This page is not endorsed by or affiliated with Tercica. For questions regarding LinkedIn Company Profiles, contact us.
Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
